Baity Glenn 4
4 · ACADIA PHARMACEUTICALS INC · Filed Jan 31, 2018
Insider Transaction Report
Form 4
Baity Glenn
VP, GC & Sec.
Transactions
- Sale
Common Stock
2018-01-29$32.39/sh−36,558$1,184,055→ 83,734 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in May 2017 and amended in November 2017.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $32.37 to $32.45 per share, inclusive.The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.